These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]αSyn transgenic mice. Diepenbroek M; Casadei N; Esmer H; Saido TC; Takano J; Kahle PJ; Nixon RA; Rao MV; Melki R; Pieri L; Helling S; Marcus K; Krueger R; Masliah E; Riess O; Nuber S Hum Mol Genet; 2014 Aug; 23(15):3975-89. PubMed ID: 24619358 [TBL] [Abstract][Full Text] [Related]
5. Intracranial administration of alpha-synuclein fibrils in A30P-synuclein transgenic mice causes robust synucleinopathy and microglial induction. Gentzel RC; Toolan D; Jinn S; Schachter JB; Ma L; Kahle PJ; Smith SM; Marcus JN Neurobiol Aging; 2021 Oct; 106():12-25. PubMed ID: 34225000 [TBL] [Abstract][Full Text] [Related]
6. In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain. Bergeron M; Motter R; Tanaka P; Fauss D; Babcock M; Chiou SS; Nelson S; San Pablo F; Anderson JP Neuroscience; 2014 Jan; 256():72-82. PubMed ID: 24128992 [TBL] [Abstract][Full Text] [Related]
7. Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain. Kahle PJ; Neumann M; Ozmen L; Muller V; Jacobsen H; Schindzielorz A; Okochi M; Leimer U; van Der Putten H; Probst A; Kremmer E; Kretzschmar HA; Haass C J Neurosci; 2000 Sep; 20(17):6365-73. PubMed ID: 10964942 [TBL] [Abstract][Full Text] [Related]
8. α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss. Trudler D; Sanz-Blasco S; Eisele YS; Ghatak S; Bodhinathan K; Akhtar MW; Lynch WP; Piña-Crespo JC; Talantova M; Kelly JW; Lipton SA J Neurosci; 2021 Mar; 41(10):2264-2273. PubMed ID: 33483428 [TBL] [Abstract][Full Text] [Related]
9. Motor impairment and aberrant production of neurochemicals in human alpha-synuclein A30P+A53T transgenic mice with alpha-synuclein pathology. Ikeda M; Kawarabayashi T; Harigaya Y; Sasaki A; Yamada S; Matsubara E; Murakami T; Tanaka Y; Kurata T; Wuhua X; Ueda K; Kuribara H; Ikarashi Y; Nakazato Y; Okamoto K; Abe K; Shoji M Brain Res; 2009 Jan; 1250():232-41. PubMed ID: 18992718 [TBL] [Abstract][Full Text] [Related]
10. Genetic deletion of Polo-like kinase 2 reduces alpha-synuclein serine-129 phosphorylation in presynaptic terminals but not Lewy bodies. Weston LJ; Stackhouse TL; Spinelli KJ; Boutros SW; Rose EP; Osterberg VR; Luk KC; Raber J; Weissman TA; Unni VK J Biol Chem; 2021; 296():100273. PubMed ID: 33428941 [TBL] [Abstract][Full Text] [Related]
11. Biochemical and morphological consequences of human α-synuclein expression in a mouse α-synuclein null background. Prasad K; Tarasewicz E; Strickland PA; O'Neill M; Mitchell SN; Merchant K; Tep S; Hilton K; Datwani A; Buttini M; Mueller-Steiner S; Richfield EK Eur J Neurosci; 2011 Feb; 33(4):642-56. PubMed ID: 21272100 [TBL] [Abstract][Full Text] [Related]
12. Enhanced motivation to alcohol in transgenic mice expressing human α-synuclein. Rotermund C; Reolon GK; Leixner S; Boden C; Bilbao A; Kahle PJ J Neurochem; 2017 Nov; 143(3):294-305. PubMed ID: 28833174 [TBL] [Abstract][Full Text] [Related]
13. α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases. Martin ZS; Neugebauer V; Dineley KT; Kayed R; Zhang W; Reese LC; Taglialatela G J Neurochem; 2012 Feb; 120(3):440-52. PubMed ID: 22060133 [TBL] [Abstract][Full Text] [Related]
14. Impact of DHA intake in a mouse model of synucleinopathy. Coulombe K; Kerdiles O; Tremblay C; Emond V; Lebel M; Boulianne AS; Plourde M; Cicchetti F; Calon F Exp Neurol; 2018 Mar; 301(Pt A):39-49. PubMed ID: 29229294 [TBL] [Abstract][Full Text] [Related]
15. alpha-Synucleinopathy models and human neuropathology: similarities and differences. Kahle PJ Acta Neuropathol; 2008 Jan; 115(1):87-95. PubMed ID: 17932682 [TBL] [Abstract][Full Text] [Related]
16. Limbic but not non-limbic kindling impairs conditioned fear and promotes plasticity of NPY and its Y2 receptor. Botterill JJ; Guskjolen AJ; Marks WN; Caruncho HJ; Kalynchuk LE Brain Struct Funct; 2015 Nov; 220(6):3641-55. PubMed ID: 25146309 [TBL] [Abstract][Full Text] [Related]
17. Aβ exacerbates α-synuclein-induced neurotoxicity through impaired insulin signaling in α-synuclein-overexpressed human SK-N-MC neuronal cells. Chang CC; Li HH; Chang YT; Ho YJ; Hsieh LJ; Chiu PY; Cheng YS; Lin CL; Lai TJ CNS Neurosci Ther; 2018 Jan; 24(1):47-57. PubMed ID: 29092095 [TBL] [Abstract][Full Text] [Related]
18. α-Synuclein (αSyn) Preformed Fibrils Induce Endogenous αSyn Aggregation, Compromise Synaptic Activity and Enhance Synapse Loss in Cultured Excitatory Hippocampal Neurons. Wu Q; Takano H; Riddle DM; Trojanowski JQ; Coulter DA; Lee VM J Neurosci; 2019 Jun; 39(26):5080-5094. PubMed ID: 31036761 [TBL] [Abstract][Full Text] [Related]
19. High expression of α-synuclein in damaged mitochondria with PLA2G6 dysfunction. Sumi-Akamaru H; Beck G; Shinzawa K; Kato S; Riku Y; Yoshida M; Fujimura H; Tsujimoto Y; Sakoda S; Mochizuki H Acta Neuropathol Commun; 2016 Mar; 4():27. PubMed ID: 27030050 [TBL] [Abstract][Full Text] [Related]
20. Bidirectional modulation of Alzheimer phenotype by alpha-synuclein in mice and primary neurons. Khan SS; LaCroix M; Boyle G; Sherman MA; Brown JL; Amar F; Aldaco J; Lee MK; Bloom GS; Lesné SE Acta Neuropathol; 2018 Oct; 136(4):589-605. PubMed ID: 29995210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]